Rabivax S 1ml Injection

Rabivax S 1ml Injection is an inactivated, purified rabies vaccine prepared on Vero cells.

It is indicated for both pre-exposure prophylaxis in high-risk populations and post-exposure prophylaxis following suspected rabies exposure in children and adults. The vaccine is supplied as a freeze-dried powder in a vial, accompanied by a 1ml diluent of Sterile Water for Injections for reconstitution.

Key Features : 

Antigen Composition: Contains purified rabies antigen (Pitman-Moore Strain 3218-VERO adapted) not less than 2.5 IU per 1ml dose.
Approved Indications: Prevents rabies in children and adults, suitable for primary immunization, booster doses, and both pre-exposure and post-exposure prophylaxis.
Target Population: Recommended for individuals at high risk of rabies exposure, such as veterinarians, laboratory personnel, animal handlers, and travelers to endemic areas, as well as those with suspected rabies exposure.
Cold-chain Storage: Requires storage between 2°C and 8°C and must not be frozen.
Route of Administration: Can be administered via intramuscular (IM) or intradermal (ID) routes.
Dosing Schedule: Offers specific schedules for pre-exposure prophylaxis (e.g., 3 doses on Days 0, 7, and 21/28 IM or ID) and post-exposure prophylaxis (e.g., 5 doses on Days 0, 3, 7, 14, and 28 IM for unimmunized individuals).
Reconstitution Requirements: Must be reconstituted with the supplied 1ml Sterile Water for Injections and used immediately, or within 6 hours if maintained at 2°C to 8°C.
Regulatory Approval: WHO Prequalified since December 20, 2018, and authorized by the Central Drugs Standard Control Organization (CDSCO) in India.